BRPI0906167A2 - uso de inibidor de serina protease no tratamento de doenças de pele. - Google Patents
uso de inibidor de serina protease no tratamento de doenças de pele.Info
- Publication number
- BRPI0906167A2 BRPI0906167A2 BRPI0906167A BRPI0906167A BRPI0906167A2 BR PI0906167 A2 BRPI0906167 A2 BR PI0906167A2 BR PI0906167 A BRPI0906167 A BR PI0906167A BR PI0906167 A BRPI0906167 A BR PI0906167A BR PI0906167 A2 BRPI0906167 A2 BR PI0906167A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- protease inhibitor
- serine protease
- skin diseases
- inhibitor use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/486—Elastase (3.4.21.36 or 3.4.21.37)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Birds (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2238608P | 2008-01-21 | 2008-01-21 | |
US657608P | 2008-01-22 | 2008-01-22 | |
PCT/IB2009/000089 WO2009093119A2 (en) | 2008-01-21 | 2009-01-21 | Use of serine protease inhibitors in the treatment of skin diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0906167A2 true BRPI0906167A2 (pt) | 2018-05-22 |
Family
ID=40901490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0906167A BRPI0906167A2 (pt) | 2008-01-21 | 2009-01-21 | uso de inibidor de serina protease no tratamento de doenças de pele. |
Country Status (8)
Country | Link |
---|---|
US (3) | US20110130338A1 (pt) |
EP (1) | EP2244728B1 (pt) |
JP (2) | JP5615184B2 (pt) |
CN (2) | CN110522905A (pt) |
AU (1) | AU2009207394B2 (pt) |
BR (1) | BRPI0906167A2 (pt) |
CA (1) | CA2712512C (pt) |
WO (1) | WO2009093119A2 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009093119A2 (en) | 2008-01-21 | 2009-07-30 | Med Discovery S.A. | Use of serine protease inhibitors in the treatment of skin diseases |
EP2405925B1 (en) * | 2009-03-10 | 2015-01-14 | Med Discovery Sa | Kallikrein inhibitors for the treatment of neutropenia |
JP5281206B1 (ja) | 2011-12-09 | 2013-09-04 | モメンティブ・パフォーマンス・マテリアルズ・ジャパン合同会社 | シリコーンゴム発泡体用組成物、シリコーンゴム発泡体の製造方法およびシリコーンゴム発泡体 |
DK2883954T3 (da) | 2012-08-08 | 2020-09-28 | Daiichi Sankyo Co Ltd | Peptidbibliotek og anvendelse deraf |
CN104903346B (zh) * | 2012-09-19 | 2019-04-09 | 财团法人台湾基督长老教会马偕纪念社会事业基金会马偕纪念医院 | Pedf衍生的多肽在预防和/或缓和皮肤老化中的用途 |
KR101437408B1 (ko) | 2012-11-05 | 2014-09-05 | 동아대학교 산학협력단 | 플라스민 및 엘라스타아제 저해 활성을 갖는 산왕거미 유래의 쿠니츠 타입 세린 프로테아제 저해 단백질 및 이를 유효성분으로 포함하는 염증 억제 및 항섬유소용해용 조성물 |
US9969573B2 (en) | 2013-05-17 | 2018-05-15 | Intelligrated Headquarters, Llc | Robotic carton unloader |
US10807805B2 (en) | 2013-05-17 | 2020-10-20 | Intelligrated Headquarters, Llc | Robotic carton unloader |
GB201322091D0 (en) * | 2013-12-13 | 2014-01-29 | Cambridge Entpr Ltd | Modified serpins for the treatment of bleeding disorders |
WO2015114144A1 (en) * | 2014-02-03 | 2015-08-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of netherton syndrome |
JP6608382B2 (ja) * | 2014-02-26 | 2019-11-20 | ルマ セラピューティクス,インク. | 紫外光治療装置及び方法 |
WO2016063991A1 (ja) * | 2014-10-24 | 2016-04-28 | 株式会社資生堂 | 角層剥離の抑制又は亢進に起因する肌状態を改善するための美容方法及び評価方法 |
MA40998A (fr) | 2014-11-21 | 2017-09-26 | Ophirex Inc | Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés |
US10597235B2 (en) | 2016-10-20 | 2020-03-24 | Intelligrated Headquarters, Llc | Carton unloader tool for jam recovery |
CN106478812B (zh) * | 2016-10-21 | 2020-11-20 | 沈阳药科大学 | 丝氨酸蛋白酶抑制剂-3及其功能、制备方法和应用 |
AU2018254586A1 (en) * | 2017-04-21 | 2019-10-17 | Genentech, Inc. | Use of KLK5 antagonists for treatment of a disease |
CA3067364A1 (en) * | 2017-06-16 | 2018-12-20 | Azitra Inc | Compositions and methods for treatment of netherton syndrome with lekti expressing recombinant microbes |
CA3112627A1 (en) * | 2018-09-24 | 2020-04-02 | Krystal Biotech, Inc. | Compositions and methods for the treatment of netherton syndrome |
US20230099101A1 (en) * | 2020-03-06 | 2023-03-30 | The Regents Of The University Of Michigan | Serine protease inhibitors for suppressing or preventing anaphylactic reaction |
CN112315897A (zh) * | 2020-11-04 | 2021-02-05 | 深圳前海鹰岗生物科技有限公司 | 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法 |
WO2023141125A2 (en) * | 2022-01-18 | 2023-07-27 | The Regents Of The University Of California | Method of inhibiting degrading protease activity in aging |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079336A (en) * | 1989-06-23 | 1992-01-07 | The Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin, analogues and methods of production |
US5252725A (en) * | 1989-06-23 | 1993-10-12 | The Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin, analogues and methods of production |
DE4214215A1 (de) * | 1992-04-30 | 1993-11-04 | Behringwerke Ag | Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen |
AUPP508798A0 (en) * | 1998-08-05 | 1998-08-27 | Biotech Australia Pty Limited | Method of treating psoriasis |
ATE278417T1 (de) * | 1999-06-18 | 2004-10-15 | Jon Bragi Bjarnason | Pharmazeutische- und kosmetischezusammensetzungen enthaldend serinproteasen aus kabeljau und deren pharmazeutische und kosmetische verwendung |
US7105172B1 (en) * | 1999-11-18 | 2006-09-12 | Bolla John D | Treatment of rosacea |
WO2002040654A2 (en) * | 2000-11-14 | 2002-05-23 | Bristol-Myers Squibb Company | A human serpin secreted from lymphoid cells lsi-01 |
US20040097481A1 (en) * | 2002-11-20 | 2004-05-20 | Benjamin Levinson | Water-soluble mesoporphyrin compounds and methods of preparation |
US20080095806A1 (en) * | 2002-11-20 | 2008-04-24 | Bathurst Ian C | Composition And Method For Treating Inflammatory Diseases Using Protease Inhibitors |
CA2521410C (en) * | 2003-04-04 | 2014-06-03 | Universite De Lausanne | Inhibitor proteins of a protease and use thereof |
WO2005117955A1 (en) * | 2004-05-19 | 2005-12-15 | Arriva Pharmaceuticals, Inc. | Treatment of atopic dermatitis with unglycosylated alpha one-antitrypsin |
EP1666075A1 (en) * | 2004-10-04 | 2006-06-07 | Switch Biotech Aktiengesellschaft | Wound dressing compositions, especially for delivery of protease inhibitors |
WO2006090282A2 (en) * | 2005-02-28 | 2006-08-31 | Universite De Lausanne | Recombinant inhibitor proteins of an hk14 protease and use thereof |
GB0525999D0 (en) * | 2005-12-21 | 2006-02-01 | Ares Trading Sa | Novel members of the kazal family of serine protease inhibitors |
CA2691849A1 (en) * | 2007-06-28 | 2008-12-31 | Novartis Ag | Kallikrein 7 modulators |
EP2183270B1 (en) * | 2007-08-17 | 2014-12-17 | Novartis AG | Use of cyclic depsipeptides to inhibit kallikrein 7 |
WO2009093119A2 (en) | 2008-01-21 | 2009-07-30 | Med Discovery S.A. | Use of serine protease inhibitors in the treatment of skin diseases |
-
2009
- 2009-01-21 WO PCT/IB2009/000089 patent/WO2009093119A2/en active Application Filing
- 2009-01-21 BR BRPI0906167A patent/BRPI0906167A2/pt not_active Application Discontinuation
- 2009-01-21 EP EP09703640.4A patent/EP2244728B1/en active Active
- 2009-01-21 CN CN201910841916.2A patent/CN110522905A/zh active Pending
- 2009-01-21 CN CN2009801099736A patent/CN101977626A/zh active Pending
- 2009-01-21 US US12/863,651 patent/US20110130338A1/en not_active Abandoned
- 2009-01-21 AU AU2009207394A patent/AU2009207394B2/en active Active
- 2009-01-21 JP JP2010542703A patent/JP5615184B2/ja active Active
- 2009-01-21 CA CA2712512A patent/CA2712512C/en active Active
-
2014
- 2014-06-25 JP JP2014130313A patent/JP5891266B2/ja active Active
- 2014-07-30 US US14/447,317 patent/US20140341881A1/en not_active Abandoned
-
2018
- 2018-12-12 US US16/217,957 patent/US11793864B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014240389A (ja) | 2014-12-25 |
EP2244728B1 (en) | 2016-08-31 |
US11793864B2 (en) | 2023-10-24 |
JP5891266B2 (ja) | 2016-03-22 |
CN110522905A (zh) | 2019-12-03 |
AU2009207394A1 (en) | 2009-07-30 |
CA2712512A1 (en) | 2009-07-30 |
US20190183989A1 (en) | 2019-06-20 |
US20140341881A1 (en) | 2014-11-20 |
EP2244728A2 (en) | 2010-11-03 |
WO2009093119A2 (en) | 2009-07-30 |
AU2009207394B2 (en) | 2015-01-22 |
JP5615184B2 (ja) | 2014-10-29 |
JP2011511766A (ja) | 2011-04-14 |
WO2009093119A3 (en) | 2009-11-26 |
US20110130338A1 (en) | 2011-06-02 |
CN101977626A (zh) | 2011-02-16 |
CA2712512C (en) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0906167A2 (pt) | uso de inibidor de serina protease no tratamento de doenças de pele. | |
CY2020043I2 (el) | Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας | |
CY2018026I1 (el) | Χρηση στρωματικων βλαστοκυτταρων λαμβανομενων απο λιπωδη ιστο στην θεραπεια συριγγιου | |
SMT201600398B (it) | Inibitori di proteina chinasi (varianti), uso di questi nel trattamento di malattie oncologiche e composizione farmaceutica basata su questi | |
SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
DK1863899T3 (da) | Hudbehandlingspræparater | |
DK1885380T3 (da) | Natriummetaarsenit til anvendelse til behandling af metastatiske neoplastiske sygdomme | |
DE602005002413D1 (de) | Wegwerfhöschen | |
DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
BRPI0909954A2 (pt) | "diazacarbazóis e métodos de uso" | |
BR112012001344A2 (pt) | derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças | |
BR112014009949A8 (pt) | métodos de tratamento de hipersecreção de muco e uso de agentes | |
FI20095600A (fi) | Koostumus ihosairauksien hoitoa varten | |
BRPI0822129A2 (pt) | Inibidores de aldh-2c no tratamento de vício. | |
BRPI0810475A2 (pt) | uso de dimiracetam no tratamento de dor crônica | |
ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
BR112014000795A2 (pt) | uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias | |
DK1933840T3 (da) | Anvendelse af delmopinol i behandlingen af acne | |
DK3156057T3 (da) | Delmopinol-belagt dyretyggeartikel til anvendelse til forebyggelsen eller behandlingen af halitosis | |
EP2225196A4 (en) | CYSTONE PROTEASE INHIBITOR FOR THE TREATMENT OF PARASITIC DISEASES | |
BRPI0714318A2 (pt) | Utilização de 2-benzoil-imidazopiridinas em terapêutica | |
BRPI0811572A2 (pt) | Uso de compostos imunomoduladores no tratamento de doenças alérgicas | |
FI20065514A0 (fi) | Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi | |
BRPI0719997A2 (pt) | Uso de epotilonas no tratamento de osteoporose e doenças relacionadas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority |
Free format text: PERDA DAS PRIORIDADES US 61/022,386 E US 61/006,576, REIVINDICADAS NO PCT/IB2009/000089, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, ITEM 28 DO ATO NORMATIVO 128/97 E NO ART. 29 DA RESOLUCAO INPI-PR 77/2013. ESTAS PERDAS SE DERAM PELO FATO DE OS DEPOSITANTES CONSTANTES DA PETICAO DE REQUERIMENTO DO PEDIDO PCT SEREM DISTINTOS DAQUELES QUE DEPOSITARAM AS PRIORIDADES REIVINDICADAS E NAO FORAM APRESENTADOS OS DOCUMENTOS COMPROBATORIOS DE CESSAO, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, ITEM 27 DO ATO NORMATIVO 128/97 E NO ART. 2 DA RESOLUCAO INPIPR 179/2017. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B12F | Other appeals [chapter 12.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |